OBJECTIVE: To compare voice and life quality of male patients with idiopathic Parkinson's disease, with individuals without disease (Control Group). METHODS: A cross-sectional study that evaluated the voice of individuals with Parkinson's disease, the group was composed of 27 subjects, aged from 39 to 79 years-old (average 59.96). The Control Group was matched on sex and age. Participants underwent voice recording. Perceptual evaluation was made using GRBASI scale, which considers G as the overall degree of dysphonia, R as roughness, B as breathiness, A as asthenia, S as strain and I as instability. The acoustic parameters analyzed were: fundamental frequency, jitter, shimmer, and harmonic to noise ratio (NHR). For vocal self-perception ana...
BACKGROUND: Dysphonia is common in Parkinson's disease (PD), but the mechanism underlying the develo...
Vocal dysfunction is well established in persons with older-onset Parkinson's disease (PD), but has ...
PURPOSE: To compare the speech and voice of Parkinson's disease (PD) patients and neurologically hea...
PURPOSE: To compare the speech and voice of Parkinson's disease (PD) patients and neurologically hea...
OBJECTIVES/HYPOTHESIS: This study explores whether changes in voice- and swallow-related QoL are ass...
To compare the speech and voice of Parkinson's disease (PD) patients and neurologically healthy elde...
Background. Psychosocial impact of dysphonia in people with Parkinson disease (PD) has been describe...
Objective To evaluate changes in perceptual and several acoustic parameters of voice in patients wit...
OBJECTIVE: Determining the profile of speech therapy of Parkinson's Disease patients and correlate t...
Objectives: “Voice” is affected more and sooner than other speech subsystems in Parkinso...
Parkinson’s disease (PD) is well known to cause voice impairments. The aim of this study is to evalu...
To evaluate voice of Iranian patients with Parkinson's disease (PD) and find any relationship betwee...
BACKGROUND: Characteristic features of hypokinetic dysarthria develop in Parkinson disease (PD). We ...
Parkinson’s Disease (PD) is a chronic neurodegenerative disease in which the symptoms of the disease...
Changes in voice and speech are thought to involve 75–90 % of people with PD, but the impact of PD p...
BACKGROUND: Dysphonia is common in Parkinson's disease (PD), but the mechanism underlying the develo...
Vocal dysfunction is well established in persons with older-onset Parkinson's disease (PD), but has ...
PURPOSE: To compare the speech and voice of Parkinson's disease (PD) patients and neurologically hea...
PURPOSE: To compare the speech and voice of Parkinson's disease (PD) patients and neurologically hea...
OBJECTIVES/HYPOTHESIS: This study explores whether changes in voice- and swallow-related QoL are ass...
To compare the speech and voice of Parkinson's disease (PD) patients and neurologically healthy elde...
Background. Psychosocial impact of dysphonia in people with Parkinson disease (PD) has been describe...
Objective To evaluate changes in perceptual and several acoustic parameters of voice in patients wit...
OBJECTIVE: Determining the profile of speech therapy of Parkinson's Disease patients and correlate t...
Objectives: “Voice” is affected more and sooner than other speech subsystems in Parkinso...
Parkinson’s disease (PD) is well known to cause voice impairments. The aim of this study is to evalu...
To evaluate voice of Iranian patients with Parkinson's disease (PD) and find any relationship betwee...
BACKGROUND: Characteristic features of hypokinetic dysarthria develop in Parkinson disease (PD). We ...
Parkinson’s Disease (PD) is a chronic neurodegenerative disease in which the symptoms of the disease...
Changes in voice and speech are thought to involve 75–90 % of people with PD, but the impact of PD p...
BACKGROUND: Dysphonia is common in Parkinson's disease (PD), but the mechanism underlying the develo...
Vocal dysfunction is well established in persons with older-onset Parkinson's disease (PD), but has ...
PURPOSE: To compare the speech and voice of Parkinson's disease (PD) patients and neurologically hea...